Kehua Bio-Engineering announces Q1 2025 convertible bond conversion

Shanghai Kehua Bio-Engineering (SZSE:002022) announced the conversion status of its "Kehua Convertible Bonds" for the first quarter of 2025. During the quarter, bonds worth CNY 11,000 (110 bonds) were converted, resulting in the issuance of 532 shares. As of March 31, 2025, the remaining outstanding amount of convertible bonds stands at CNY 225,213,100 (2,252,131 bonds). The company's total share capital increased to 514,318,121 shares due to the conversions. The conversion price remains at CNY 20.64 per share, with the conversion period running from February 3, 2021, to July 27, 2026. The announcement also references previous adjustments to the conversion price due to stock buybacks and equity distribution plans. Investors are advised to consult the full announcement on the Juchao Information website for further details.